Prolonged Exposure to Lipopolysaccharide Induces NLRP3-Independent Maturation and Secretion of Interleukin (IL)-1β in Macrophages
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Upon sensing of microbial infections or endogenous danger signals in macrophages, inflammasome signaling plays a significant role in triggering inflammatory responses via producing interleukin (IL)-1β. Recent studies revealed that active caspase-1, a product of the inflammasome complex, causes maturation of inactive pro-IL-1β into the active form. However, the underlying mechanism by which this leaderless cytokine is secreted into the extracellular space remains to be elucidated. In this study, we demonstrated that prolonged lipopolysaccharide (LPS) treatment to macrophages could trigger the unexpected maturation and extracellular release of IL-1β through a nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3)-independent manner. Short-term treatment (less than 6 h) of LPS induced robust production of the IL-1β precursor form inside cells but did not promote the maturation and secretion of IL-1β in bone marrow-derived macrophages or peritoneal macrophages. Instead, prolonged LPS treatment (more than 12 h) led to a significant release of matured IL-1β with no robust indication of caspase-1 activation. Intriguingly, this LPS-triggered secretion of IL-1β was also observed in NLRP3-deficient macrophages. In addition, this unexpected IL-1β release was only partially impaired by a caspase-1 and NLRP3 inflammasome inhibitor. Collectively, our results propose that prolonged exposure to LPS is able to drive the maturation and secretion of IL-1β in an NLRP3 inflammasome-independent manner.
Abstract
Upon sensing of microbial infections or endogenous danger signals in macrophages, inflammasome signaling plays a significant role in triggering inflammatory responses via producing interleukin (IL)-1β. Recent studies revealed that active caspase-1, a product of the inflammasome complex, causes maturation of inactive pro-IL-1β into the active form. However, the underlying mechanism by which this leaderless cytokine is secreted into the extracellular space remains to be elucidated. In this study, we demonstrated that prolonged lipopolysaccharide (LPS) treatment to macrophages could trigger the unexpected maturation and extracellular release of IL-1β through a nucleotide-binding oligomerization domain-like receptor family, pyrin domain-containing 3 (NLRP3)-independent manner. Short-term treatment (less than 6 h) of LPS induced robust production of the IL-1β precursor form inside cells but did not promote the maturation and secretion of IL-1β in bone marrow-derived macrophages or peritoneal macrophages. Instead, prolonged LPS treatment (more than 12 h) led to a significant release of matured IL-1β with no robust indication of caspase-1 activation. Intriguingly, this LPS-triggered secretion of IL-1β was also observed in NLRP3-deficient macrophages. In addition, this unexpected IL-1β release was only partially impaired by a caspase-1 and NLRP3 inflammasome inhibitor. Collectively, our results propose that prolonged exposure to LPS is able to drive the maturation and secretion of IL-1β in an NLRP3 inflammasome-independent manner.
참고문헌 (25)
- Dinarello CA, "Interleukin-1 in the pathogenesis and treatment of inflammatory diseases", Blood, 117, pp.3720~3732 (2011)
- Rubartelli A, "A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence", EMBO J, 9, pp.1503~1510 (1990)
- Thornberry NA, "A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes", Nature, 356, pp.768~774 (1992)
- Keller M, "Active caspase-1 is a regulator of unconventional protein secretion", Cell, 132, pp.818~831 (2008)[DOI]
- Agostini L, "NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder", Immunity, 20, pp.319~325 (2004)[DOI]
- Fernandes-Alnemri T, "AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA", Nature, 458, pp.509~513 (2009)[DOI]
- Latz E, "Activation and regulation of the inflammasomes", Nat. Rev. Immunol., 13, pp.397~411 (2013)[DOI]
- Je-Wook Yu, "Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance", Archives of Pharmacal Research, 39(11), pp.1503~1518 (2016), 대한약학회
- Haneklaus M, "Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments", Curr. Opin. Immunol., 25, pp.40~45 (2013)
- Ghonime MG, "Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function", J. Immunol., 192, pp.3881~3888 (2014)[DOI]
- Juliana C, "Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation", J. Biol. Chem., 287, pp.36617~36622 (2012)[DOI]
- Fernandes-Alnemri T, "Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome", J. Immunol., 191, pp.3995~3999 (2013)[DOI]
- He Y, "TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo", J. Immunol., 190, pp.334~339 (2013)[DOI]
- Hwang I, "Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4", Immunol. Cell Biol., 93, pp.591~599 (2015)[DOI]
- Vigano E, "Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes", Nat. Commun., 6, pp.8761~ (2015)[DOI]
- Tateda K, "Lipopolysaccharide-induced lethality and cytokine production in aged mice", Infect. Immun., 64, pp.769~774 (1996)
- Eltom S, "TLR4 activation induces IL-1beta release via an IPAF dependent but caspase 1", 11, Respir. Res., pp.2014, 15[DOI]
- Yu JW, "Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants", Mol. Cell, 28, pp.214~227 (2007)[DOI]
- Fernandes-Alnemri T, "The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation", Cell Death Differ, 14, pp.1590~1604 (2007)[DOI]
- Broz P, "Inflammasomes: mechanism of assembly, regulation and signalling", Nat. Rev. Immunol., 16, pp.407~420 (2016)[DOI]
- Mariathasan S, "Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation", Nat. Rev. Immunol., 7, pp.31~40 (2007)[DOI]
- Py BF, "Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity", Mol. Cell, 49, pp.331~338 (2013)[DOI]
- Kayagaki N, "Noncanonical inflammasome activation by intracellular LPS independent of TLR4", Science, 341, pp.1246~1249 (2013)
- Hagar JA, "Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock", Science, 341, pp.1250~1253 (2013)[DOI]
- Stammler D, "Inhibition of histone deacetylases permits lipopolysaccharide-mediated secretion of bioactive IL-1beta via a caspase-1-independent mechanism", J. Immunol., 195, pp.5421~5431 (2015)[DOI]